Micro
Developing
Active
Eli Lilly memperluas akses Zepbound untuk pertumbuhan jangka panjang
Skor
0,5
Kecepatan
▲ 0,0
Artikel
9
Sumber
4
Ringkasan
Artikel ini termasuk dalam narasi ini jika membahas perluasan akses Zepbound oleh Eli Lilly dan prospek pertumbuhannya dalam jangka panjang.
Artikel Terkait
Jim Cramer Likes Eli Lilly’s (LLY) New Deal
Yahoo Finance
·
Apr 05, 2026
Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight
Nasdaq
·
Apr 04, 2026
Eli Lilly secures long-awaited FDA approval for its obesity pill. Here's what to know
CNBC
·
Apr 01, 2026
The cutthroat battle for the US weight-loss drug market
BBC Business
·
Mar 23, 2026
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook
Yahoo Finance
·
Mar 22, 2026
Sumber
Jim Cramer Likes Eli Lilly’s (LLY) New Deal
Yahoo Finance
Is Eli Lilly and Company (LLY) The Best Pharma Stock …
Yahoo Finance
Lini Waktu
Terakhir Diperbarui
Mar 22, 2026